
BEIJING, March 11 (Xinhua) -- China will strengthen management and supervision of vaccines to ensure their safety, the country's top drug regulator said Monday.
Chinese lawmakers have finished their first reading of a draft law on vaccine management, and solicited public opinions, Jiao Hong, head of the National Medical Products Administration, told a press conference on the sidelines of the annual legislative session.
China's vaccines are generally safe, Jiao said, adding that the development of a vaccine management mechanism with long-term effects is underway.
Vaccine-producing companies should build a sound quality management system and product safety tracing and risk reporting mechanisms.
Provincial drug regulators should enhance on-site checks on vaccine producers while the national administration will strengthen random checks, she said.
China will develop and train national and provincial professional inspectors to enhance supervision capabilities, she added.
Fire brigade in Shanghai holds group wedding
Tourists enjoy ice sculptures in Datan Town, north China
Sunset scenery of Dayan Pagoda in Xi'an
Tourists have fun at scenic spot in Nanlong Town, NW China
Harbin attracts tourists by making best use of ice in winter
In pics: FIS Alpine Ski Women's World Cup Slalom
Black-necked cranes rest at reservoir in Lhunzhub County, Lhasa
China's FAST telescope will be available to foreign scientists in April
"She power" plays indispensable role in poverty alleviation
Top 10 world news events of People's Daily in 2020
Top 10 China news events of People's Daily in 2020
Top 10 media buzzwords of 2020
Year-ender:10 major tourism stories of 2020
No interference in Venezuelan issues
Biz prepares for trade spat
Broadcasting Continent
Australia wins Chinese CEOs as US loses